| Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses R Bos, L Rutten, JEM van der Lubbe, MJG Bakkers, G Hardenberg, ... npj Vaccines 5 (1), 91, 2020 | 380 | 2020 |
| Immunogenicity and efficacy of one and two doses of Ad26. COV2. S COVID vaccine in adult and aged NHP L Solforosi, H Kuipers, M Jongeneelen, SK Rosendahl Huber, ... Journal of Experimental Medicine 218 (7), 2021 | 62 | 2021 |
| Ad26. COV2. S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease JEM van Der Lubbe, SK Rosendahl Huber, A Vijayan, L Dekking, ... npj Vaccines 6 (1), 39, 2021 | 62 | 2021 |
| SARS-CoV-2 binding and neutralizing antibody levels after Ad26. COV2. S vaccination predict durable protection in rhesus macaques R Roozendaal, L Solforosi, DJ Stieh, J Serroyen, R Straetemans, A Dari, ... Nature Communications 12 (1), 5877, 2021 | 33 | 2021 |
| Mini-HA is superior to full length hemagglutinin immunization in inducing stem-specific antibodies and protection against group 1 influenza virus challenges in mice JEM Van der Lubbe, JWA Verspuij, J Huizingh, SPR Schmit-Tillemans, ... Frontiers in immunology 9, 2350, 2018 | 32 | 2018 |
| Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge JEM van der Lubbe, J Huizingh, JWA Verspuij, L Tettero, ... npj Vaccines 3 (1), 25, 2018 | 23 | 2018 |
| Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines. 2020; 5: 91 R Bos, L Rutten, JEM Van Der Lubbe, MJG Bakkers, G Hardenberg, ... DOI: https://doi. org/10.1038/s41541-020-00243-x. PMID: https://www. ncbi …, 2020 | 22 | 2020 |
| Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization JEM van der Lubbe, J Vreugdenhil, S Damman, J Vaneman, J Klap, ... Virology journal 14, 1-12, 2017 | 19 | 2017 |
| Immunogenicity and protective efficacy of one-and two-dose regimens of the Ad26. COV2. S COVID-19 vaccine candidate in adult and aged rhesus macaques L Solforosi, H Kuipers, SKR Huber, JEM van der Lubbe, L Dekking, ... bioRxiv, 2020.11. 17.368258, 2020 | 8 | 2020 |
| Immunogenicity of one-and two-dose regimens of the Ad26. COV2. S COVID-19 vaccine candidate in adult and aged rhesus macaques L Solforosi, H Kuipers, SKR Huber, JE van der Lubbe, L Dekking, ... BioRxiv, 2020 | 5 | 2020 |
| Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. Npj Vaccines, 5 (1), 1–11 R Bos, L Rutten, JEM van der Lubbe, MJG Bakkers, G Hardenberg, ... | 4 | 2020 |
| Ad26. COV2. S-elicited immunity protects against G614 spike variant SARS-CoV-2 infection in Syrian hamsters and does not enhance respiratory disease in challenged animals with … JEM van der Lubbe, SK Rosendahl Huber, A Vijayan, L Dekking, ... bioRxiv, 2021.01. 08.425915, 2021 | 3 | 2021 |
| Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen M Swart, H Kuipers, F Milder, M Jongeneelen, T Ritschel, J Tolboom, ... npj Vaccines 8 (1), 176, 2023 | 2 | 2023 |
| Booster vaccination with Ad26. COV2. S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA. 2 M Swart, J Van Der Lubbe, S Schmit-Tillemans, E Van Huizen, J Verspuij, ... npj Vaccines 8 (1), 40, 2023 | 2 | 2023 |
| Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice LP Kil, J Vaneman, JEM van der Lubbe, D Czapska-Casey, ... Plos one 14 (11), e0225063, 2019 | 2 | 2019 |
| Broadly protective influenza vaccines paving the road towards the clinic JEM van der Lubbe | | 2019 |
| The biodistribution of the spike protein after Ad26. COV2. S vaccination is unlikely to play a role in vaccine-induced immune thrombotic thrombocytopenia SM Martínez, S Khan, J van der Lubbe, L Solforosi, LMM Costes, Y Choi, ... Uncharted Territory, 95, 0 | | |
